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The BeWo trophoblast cell line does not constitutively express the tryptophan degrading enzyme indolamine
2,3-dioxygenase (IDO), nor can IDO expression be induced by gamma interferon. This correlates with the
inability of BeWo cells to control the growth of Chlamydophila abortus, in contrast to effects observed in HeLa
cells treated with gamma interferon.
Chlamydophila abortus (previously Chlamydia psittaci immu-
notype 1) is an obligate intracellular gram-negative bacterium
that causes abortion in ruminants and humans (7). Immuno-
logical control of this organism is dependent on the ability of
the host to mount a cell-mediated response, and protection is
strongly associated with gamma interferon (IFN-) production
(9, 17). This is also true for the related organisms Chlamydia
trachomatis and Chlamydophila pneumoniae (24, 25). Control
of C. abortus growth by IFN- in ovine cells appears to be
linked to tryptophan (trp) catabolism, since addition of trp will
reverse the effects of IFN- and can alter the threshold for
IFN--mediated persistence in tissue culture (2). However, the
relationship between IFN-, trp catabolism, and control of
Chlamydia or Chlamydophila spp. is complex and is dependent
on both host and pathogen factors, such as sensitivity to IFN-,
availability of intracellular trp pools, and the presence of func-
tional trp synthase genes in the chlamydial genome (13, 22, 26).
Disease pathogenesis of C. abortus infection follows a dis-
tinctive pattern. Abortion in humans appears to be a result of
primary gestational infection after direct contact with infected
ruminant material, whereas abortion in ruminants can be a
result of either primary gestational infection or of a persistent,
subclinical infection established prior to pregnancy (7, 12).
This link between disease and pregnancy suggests that the
organism exploits the immunological and/or physiological sta-
tus of the pregnant host during this period. By failing to reject
the semiallogeneic fetus, the maternal immune system does
not react in a manner predicted by the self-nonself model of
immune activation, prompting the suggestion that the mater-
nal immune system is suppressed during pregnancy (18). More
precisely, it has subsequently been shown that there is immune
modulation during pregnancy rather than general maternal
immune suppression. This is manifested by a decreased pro-
duction of IFN- and a bias towards Th2-type or regulatory
cytokines in the placenta. It appears that production of inflam-
matory cytokines, particularly at the maternofetal interface, is
incompatible with successful pregnancy (5, 23).
Cytokine biasing is not the only mechanism that can explain
the maternal acceptance of the semiallogeneic fetus. There is
also evidence for induction of maternal T-cell tolerance to the
fetal allograft. This is mediated by trp deprivation as a result of
constitutive expression of the trp-degrading enzyme indoleam-
ine 2,3-dioxygenase (IDO) in placental trophoblast cells (21).
Although this was first shown in mice, IDO expression has
subsequently been demonstrated in human placenta tropho-
blasts (15). This raises an interesting question: why does C.
abortus infect trophoblast cells and continue to grow in an
environment where trp is readily degraded? It also provokes
the following question: what role (if any) does IFN- play in
IDO expression and control of infection in trophoblast cells?
In an attempt to address these points, an in vitro model of
trophoblast infection was established with the BeWo tropho-
blast cell line. BeWo cells originate from a naturally occurring
human choriocarcinoma, and, although transformed, they
share several features with normal human trophoblasts (14).
They express HLA-G transcripts and they also express func-
tional IFN- receptors (6, 8). We therefore reasoned that these
cells offer a good system to address our questions. BeWo cells
were purchased from the European Collection of Cell Cultures
(ECACC; Salisbury, United Kingdom) and were routinely
maintained in antibiotic-free Iscove’s modified Dulbecco’s me-
dium (IMDM; Life Technologies, Paisley, United Kingdom)
supplemented with 10% fetal bovine serum (FBS; Labtech
International, East Sussex, United Kingdom). HeLa cells
(ECACC) were used as a control cell line throughout and were
cultured under the same conditions as those for BeWo cells.
BeWo (104 cells/well) and HeLa (5  103 cells/well) were
seeded into 96-well plates (Corning Costar, High Wycombe,
United Kingdom) in 100 l of IMDM supplemented with 5%
FBS and were allowed to adhere overnight. The cells were then
treated with 100 U of recombinant human IFN- (R&D Sys-
tems, Abingdon, United Kingdom)/ml and were incubated for
a further 24 h. The medium was then removed from the wells,
and the cells were infected with C. abortus at a concentration
of 5  102 inclusion-forming units per well, with a multiplicity
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of infection of approximately 0.05 to 0.1. The inoculum was
removed after 3 h and was replaced with 200 l of IMDM
supplemented with 5% FBS. The cells were cultured for a
further 5 days (approximately two cycles of C. abortus growth),
and then the supernatants were harvested and analyzed for the
presence of chlamydial lipopolysaccharide (LPS) by a specific
monoclonal antibody-based capture enzyme-linked immu-
nosorbent assay. This LPS enzyme-linked immunosorbent as-
say has been shown to correlate well with the number of in-
clusions in cells and also with the number of infectious
elementary bodies in the culture supernatants, thereby giving a
rapid quantification of C. abortus growth (2). Each experiment
was conducted in quadruplicate and repeated at least twice.
Results were analyzed with the Student’s t test.
The results of IFN- treatment are shown in Fig. 1. Growth
of the organism was more rapid in HeLa cells than in BeWo
cells, as shown by the amounts of LPS detected. This corre-
lated with lysis of HeLa cells and release of inclusions at this
point, whereas there was no lysis in the BeWo cells, despite the
presence of multiple inclusions (data not shown). Secondly,
treatment of BeWo cells with IFN- did not affect the growth
of C. abortus, whereas growth was inhibited in HeLa cells (P 
0.001). The failure of BeWo cells to control chlamydial growth
in response to IFN- treatment is unusual, since this is a
common host defense mechanism against this family of organ-
isms. In fact, the failure of IFN- to control pathogen growth
in BeWo cells was not limited to C. abortus. We also found that
neither IFN- nor IFN- could control the replication of Sem-
liki Forest virus in BeWo cells, but both did so in HeLa cells
(data not shown). We found no evidence that BeWo cells
themselves produce biologically active IFN.
Trophoblast cells are a key component of the human hemo-
chorial placenta, forming an interface between the fetus and
mother. It is known that there are certain intracellular mech-
anisms that operate to regulate their response to cytokine
exposure. This is important for maintaining the critical balance
of invasiveness into maternal decidua while avoiding immuno-
logical rejection. For example, there is both in vitro and in vivo
evidence that IFN- is unable to induce class II expression in
trophoblast cells. Detailed studies of JEG-3 cells (a subclone of
BeWo) have shown that this is not due to a lack of IFN-
receptors but rather is due to intracellular regulatory events
following receptor ligation, specifically negative regulation or
silencing of the class II transactivator. However, IFN- can
induce transcription of the genes encoding the Janus kinases
(Jak1 and Jak2) and also the signal transducer and activator of
transcription (STAT1), demonstrating that the signaling
components of the IFN- receptor are operational (10, 20).
Since C. abortus grows in BeWo cells irrespective of IFN-
treatment, we were interested to know if these cells were de-
ficient in the constitutive and/or induced expression of IDO.
This was done by studying expression of mRNA encoding IDO
in BeWo and HeLa cells with PCR following IFN- treatment.
BeWo and HeLa cells were grown to subconfluence in 75-
cm2 tissue culture flasks (Corning Costar) and then were
treated with 100 U of IFN-/ml. Total RNA was isolated from
the cells after a further 24 h using the acid phenol/guanidine
thiocyanate method (3). RNA (2 g) was converted to single-
stranded cDNA with AMV Reverse Transcriptase (Roche,
Lewes, United Kingdom) and oligo(dT)12-15 as the primer.
Thirty cycles of the PCR, each of 1 min at 94°C, 1 min at 55°C,
and 1 min at 72°C, were then performed in order to amplify
either the IDO cDNA or the GAPDH cDNA (as an internal
control). The primers used for amplifying the IDO cDNA (11)
should result in the amplification of a 324-bp fragment of the
IDO cDNA, whereas the primers 5-CCCATGGCAAGTTCC
ACGGC-3 and 5-CACCCTGTTGCTGTAGCCGA-3 should
amplify a 818-bp fragment of the GAPDH cDNA. The results
FIG. 1. Growth of C. abortus in BeWo and HeLa cells cultured in
medium alone (hatched bar), medium containing 100 U of IFN-/ml
(open bar), or medium containing 100 U of IFN-/ml and 500 g of
L-tryptophan/ml (filled bar). Error bars represent the standard errors
of the means of quadruplicate observations.
FIG. 2. Products from reverse transcription-PCR amplification of
IDO and GAPDH mRNAs visualized on a 1% agarose gel. Lanes 1 to
4 correspond to the amplification products obtained from RNA iso-
lated from HeLa cells grown in medium alone, HeLa cells treated with
100 U of IFN-/ml, BeWo cells in medium alone, and BeWo cells
treated with 100 U of IFN-/ml, respectively. Lane 5 contains a 1-kb
molecular size marker.
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of the PCR amplification are presented in Fig. 2. There is no
constitutive expression of mRNA encoding IDO in either cell
line. However, expression was induced by IFN- in HeLa cells
but not in BeWo cells. This pattern fits with the observations
shown in Fig. 1, namely that C. abortus grows in both cell lines
and that IFN- inhibits the growth in HeLa but not in BeWo
cells. Based on the assumption that this data reflects trp deg-
radation by IDO, addition of trp to the cells should reverse the
antichlamydial effects of IFN-.
After removal of the inoculum, L-trp (Sigma, Poole, United
Kingdom) was added to the culture medium to a final concen-
tration of 500 g/ml. The results are shown in the final columns
in Fig. 1. Addition of trp made no difference to the growth of
C. abortus in BeWo cells (P 0.5) but resulted in growth of the
organism in IFN--treated HeLa cells (P  0.001). The rever-
sal in the HeLa cells was not complete, probably because the
antichlamydial effects of IFN- are highly dose dependent such
that as the concentration of IFN- increases, the effect of trp
decreases (2).
BeWo cells do not express IDO either constitutively or in
response to IFN- treatment. We have confirmed that the lack
of IFN- responsiveness is not due to the failure of BeWo cells
to express the IFN- receptor (CD119). BeWo and HeLa cells
were removed from flasks by using nonenzymatic detachment
(Accutase; Innovative Cell Technologies, La Jolla, Calif.) and
reacted with a mouse monoclonal antibody recognizing human
CD119 (Serotec, Oxford, United Kingdom). Cells were then
reacted with a biotin conjugated goat anti-mouse immunoglob-
ulin (Dako, Cambridge, United Kingdom) followed by strepta-
vidin-allophycocyanin (Becton Dickinson, San Jose, Calif.).
VPM 20, a mouse monoclonal antibody against a ruminant
pestivirus nonstructural protein, was used as an isotype-
matched (immunoglobulin G2a) control. Data acquisition and
analysis was performed with a two-laser four-color FACSCalibur
flow cytometer and CellQuest software (Becton Dickinson,
Mountain View, Calif.). Both BeWo and HeLa cells stained
positively for CD119 (Fig. 3). There is some background stain-
ing with the control antibody on BeWo cells, most likely as a
result of binding via Fc receptors (FcR).
The BeWo cell line, therefore, offers a useful system for
dissecting the mechanisms of control of intracellular patho-
gens, particularly those pathogens that are under control of
IFN-, where multiple intracellular biosynthetic pathways are
triggered. For example, it has been suggested that the persis-
FIG. 3. Flow cytometry analysis of IFN- receptor (CD119) expression on BeWo and HeLa cells. Cells were stained by a three-step procedure
involving a primary mouse monoclonal antibody followed by an anti-mouse biotin conjugate and then streptavidin-allophycocyanin. Cells stained
with a monoclonal antibody reacting with human CD119 are shown by the heavy solid line. The dotted line shows cells reacted with an
isotype-matched control, and the light solid line shows cells stained with the second- and third-step reagents only.
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tence, pathogenesis, and tissue tropism of different species and
strains of C. trachomatis are linked to IFN- responsiveness
and trp biosynthesis (26). It is also known that not all gyneco-
logic cancer cells respond to IFN- treatment by upregulating
IDO expression, compatible with our observations of BeWo
cells (16). Interestingly, constitutive IDO expression by toler-
izing the reactive T cells via trp starvation may be one method
of tumor immune evasion (19). This is not the case with BeWo,
despite their placental origin. It would be interesting to study
this in other trophoblast lines, but to date many of the estab-
lished lines have a common origin (19).
These data also support the fact that immunological control
of pathogens at the maternofetal interface is different from
that in the periphery. The intracellular and extracellular reg-
ulatory mechanisms that are in place to prevent maternal allo-
rejection render this tissue particularly susceptible to certain
invasive intracellular organisms, such as C. abortus and Toxo-
plasma gondii. It should be noted that constitutive IDO expres-
sion is not uniform in human placental trophoblast, as there
are areas of low expression (15). This could explain why C.
abortus grows in an apparently inhospitable environment.
The mechanisms of infectious abortion vary from organism
to organism and reflect a close link between the levels of
hormones essential for the maintenance of pregnancy and the
cytokine environment (7). The very presence of inflammatory
cytokines, such as tumor necrosis factor alpha, interleukin 2,
and IFN-, can be abortifacient (23). It is therefore possible
that infectious abortion represents a form of immunological
amputation of the infected fetal unit for the preservation of the
mother (4). Although the self-nonself and Danger models of
immune activation have different explanations for the role of
IDO in the placenta and maternal acceptance of the semiallo-
geneic fetus, both models predict that placental infection pre-
sents a problem for pathogen control without causing fetal
damage (1). Therefore, by studying the mechanisms of C. abor-
tus-induced pathology we may also elucidate some of the im-
munoregulatory processes involved in the maintenance of nor-
mal pregnancy.
This work was funded by the Scottish Executive Environmental and
Rural Affairs Department (SEERAD).
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